2022·6th Future Healthcare 100 Summit Announces 'Weilan Award: Top 30 Young Scientists'
/
Medicine, an Eternal Topic for Humanity. The struggle against disease has been a persistent endeavor since the era of traditional medicine. Advances in medicine have extended human life in a physical sense, while innovations in healthcare continue to drive technological breakthroughs. It is these very advancements that make possible the hope articulated by Academician Ge Junbo: “to enable every patient to live with dignity and quality.”
As the creators of medical breakthroughs, emerging young scientists are rising on the wave of healthcare innovation, becoming a key driving force in the new round of technological revolution and medical transformation. They are scholars committed to practical implementation and R&D professionals who avoid empty fantasies and hollow reputations. By keenly identifying domestic technological shortcomings and leveraging their deep expertise in their respective fields, they have successfully achieved technological breakthroughs in China’s medical sector and continue to lead their teams in conquering new frontiers in medicine.
Given the significant role of young scientists in driving innovation within the healthcare sector, VCBeat introduced the “Weilan Award: Top 30 Young Scientists” for the first time in its 2022 Future Healthcare 100 selection. This initiative aims to identify thirty outstanding young scientists at the forefront of medical innovation, discovering and supporting pioneering talents who demonstrate a spirit of healthcare innovation and future impact. Following a two-month period of open calls and institutional nominations, the Organizing Committee of the Future Healthcare 100 reviewed and refined the application materials submitted for the “Weilan Award: Top 30 Young Scientists,” and compiled an overview of the candidates’ profiles along with their key research areas and breakthroughs.
Hardcore Innovation · Focusing on Technological Breakthroughs and Clinical Needs
In the contemporary medical field, multiple projects developed by young scientists have surpassed international leading standards, with numerous technologies and products filling domestic gaps. Working on the front lines of technological research and development, they are driving one breakthrough after another in China’s medical technology sector.
The young scientists nominated for the 2022 Future Healthcare Top 100 “Weilan Award: Top 30 Young Scientists” hail from diverse fields and focus on different disease-specific research areas, driving the development of the healthcare industry within their respective domains.
Supported by government policies, a robust regulatory framework, and investments from relevant departments and all sectors of society, the artificial intelligence (AI) sector in healthcare has gained significant popularity. Among the young scientists nominated this time, 26.8% are focused on AI and healthcare informatization; additionally, 9.8% are concentrated in the field of innovative and breakthrough drug development; and another 4.9% are dedicated to the design and research and development of cutting-edge medical devices.
Not only are the research fields diverse, but the diseases targeted by candidate young scientists also vary widely. Among them, 14.6% of candidates focus on oncology; 9.8% conduct research in cardiovascular diseases; and an additional 7.3% each concentrate on neuroscience and mental health, as well as rehabilitation.
For the 2022 Future Healthcare Top 100 “Weilan Award: 30 Young Scientists” selection, numerous outstanding young scientists with significant personal, industry, and innovation influence in the medical field have entered the competition.
The young scientists competing in this edition represent a distinguished gathering of exceptional talent. Among them are recipients of various prestigious national awards, as well as young scientists who have not previously received other notable honors. Eighty-four percent of the awardees hold the title of professor or an equivalent academic rank, and 25 have experience studying or working at top-tier overseas universities and research institutions. These young scientists are elite research professionals striving for major breakthroughs in forward-looking basic research. They have published numerous papers in leading international academic journals such as Nature and Science, and have undertaken multiple key research projects under the National Key R&D Program, the Ministry of Science and Technology, and the National Natural Science Foundation of China. They have filed for or been granted more than 500 national invention patents, exerting significant influence in fields such as orthopedics, oncology, colorectal cancer, and heart disease. Their research achievements constitute a core driving force for medical innovation.
Guiding basic research with the spirit of scientific inquiry and serving clinical applications with original achievements. On one hand, they identify directions for basic research based on problems encountered in clinical practice; on the other, they translate laboratory findings into diagnostic and therapeutic techniques and methods for clinical use. By driving new breakthroughs in biomedicine through innovation in frontier research, they truly achieve a balance between basic research outcomes and clinical applications, making their own contributions to human survival and health. It is evident that outstanding young scientists and their research complement each other: individuals gain recognition through superior project outcomes, while original achievements thereby serve the cause of medical and healthcare advancement.
Amidst the winds and rains of change, a new era will surely see new pioneers take the helm, steering the course and sparking fresh transformations.
Young scientists have become an indispensable and key force driving medical innovation. Scientists shortlisted for this ranking will receive:
Recommended Resources for the Entire Community:Online article dissemination to increase exposure, with recommendations across the entire VCBeat community; post-publication matchmaking services with industry, capital, and research institutions are provided to deepen exchanges and cooperation with leading enterprises and research organizations.
Invited to Attend the 2022 Top 100 Future Healthcare Conference:Shortlisted scientists are invited to attend the conference and the awards ceremony, with opportunities to participate in the Forum on Translation of Scientific Research Achievements and the Scientists’ Forum. Together with industry pioneers, they will explore the latest development trends and future frontier technologies in the life and health sector. Selected for inclusion in the “2022 VB100 List Guide”:
Shortlisted scientists will be featured in the "2022 VB100 List Guide":Showcasing the achievements and profiles of shortlisted scientists in areas such as technological specialization and industrialization exploration, the guidelines will be released both online and offline concurrently with the 2022 Top 100 Future Healthcare Companies Conference.
In late May or early June 2022 (tentative dates subject to the pandemic situation), the 6th Future Healthcare Top 100 Conference will be held at Shishan, Suzhou. The conference will undergo comprehensive upgrades in themes and content, release rankings for the Future Healthcare Top 100 across five major sectors and over 20 value-driven fields, and host more than 20 thematic forums. Stay tuned to the Future Healthcare Top 100 Conference for more highlights from the healthcare industry.
The Future Healthcare Top 100 List, established in 2015, is China’s first ranking dedicated to innovative healthcare companies that are not publicly listed. It was launched by VCBeat, VB100, and Eggshell Research Institute. The list aims to identify Chinese innovators who truly represent the future of healthcare, uncover the core driving forces behind China’s future healthcare industry, and promote innovation and transformation within the health and medical sector. Over the past six years, the Future Healthcare Top 100 List system has been continuously enriched, gradually evolving into a global innovative healthcare ecosystem ranking that serves enterprises, investment institutions, hospitals, and industrial parks.
As of 2021, the Future Healthcare Top 100 list had conducted six rounds of evaluations, cumulatively releasing 125 lists/awards. With 2,464 listed companies and a total corporate valuation of RMB 3.301685 trillion, it continuously identifies the most representative innovative and high-potential enterprises in the healthcare industry, offering a broader perspective to observe and discover the direction of transformation in the health and medical sector. Additionally, 206 industry leaders (entrepreneurs/investors/industry experts) and 170 innovative entities (companies/investment institutions/industrial parks) stood out from the selection process and received relevant awards. The 2022 Future Healthcare Top 100 series will include the Main List of Future Healthcare Top 100, the Value Sector List of Future Healthcare Top 100, the Future Healthcare Top 100 Pengcheng Award, and the Future Healthcare Top 100 Weilan Award.
How Chinese Healthcare Professionals Can Ride the Wave and Rise Against the Wind
Open New Windows to Embrace New Vistas in the Future
"The sound of the wind can be heard here."
2022 Top 100 Future Healthcare Companies List · Weilan Award
Let us wait and see.
Editor: Wang Meilin
Yang Xinmei
Guo Ye
/
Conference Date: Late May or Early June 2022
Conference Venue: Shishan International Conference Center, Suzhou, China
Limited-Time Offer: Conference All-Access Pass
Purchase Channels:Search for the “VB100” mini program on WeChat to make a purchase.
Two types of general admission passes are available for public purchase at this conference:
899 Yuan [VB100 All-Access Pass, Meals Not Included],¥1,299 [VB100 All-Access Pass with Meals]Limited-Time Offer · Conference All-Access PassSave ¥630 off the original price, now as low as ¥269Onset:
Your trust will grant you the following benefits:
1. All-access pass for the forum, exhibition, and interactive activities (separate registration required for certain segments such as LPGP)
2. On-site Resource Coordination and Communication Group
3. Authorized materials for guests, including PPTs, conference proceedings, and public reports
4. Lunch vouchers during the conference (only for those with meal tickets)
Special Note:
1. Duration of this limited-time offerImportant milestone updates from today until the next meeting;
2. Ticket prices will be adjusted as information regarding the conference theme, speakers, topics, and exhibitors is unveiled,Increase by 100 yuan each time until the original price is restored;
3、Upon the conclusion of this limited-time offer,Ticket prices will rise to 369 yuanOnset
Scan the QR code to register for the 2022 · 6th Future Healthcare Top 100 Conference
2022 Future Healthcare 100 Conference Inquiry
